Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler

Completed · Not applicable

Conditions studied: Gene Expression

In brief

To compare gene expression stimulated by a semi-permanent filler and a biostimulator via punch biopsy

Key facts

Study ID

NCT05620043

Run by

Galderma R&D

People needed

21

Starts

2022-09-28

Expected to finish

2023-11-06

Last updated by the study team

2026-04-15

Who can join

Age: 22 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subject with a minimum of shallow nasolabial fold (NLF) contour deficiencies as assessed via the wrinkle assessment scale
• Subject with identical WAS scores on both NLFs
• Ability of giving consent for participation in the study
• Agreement to have skin biopsies on NLFs

You may not qualify if…

• Significant NLF asymmetry, or different WAS score on each NLF
• Pregnant, planning pregnancy during the course of the study or breastfeeding
• History of allergy or hypersensitivity to any ingredient of the treatment products
• History of allergy or hypersensitivity to anesthetics or lidocaine

Where it is running

• Miami Dermatology & Laser Institute — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.